Akinsanya Karen
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Akinsanya Karen. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SDGR | President of R&D, Therapeutics | Sale | 3,345 | $25.00 | $83,625 | Apr 14, 2025 |
| SDGR | President of R&D, Therapeutics | Award / Grant | 15,625 | — | — | Mar 3, 2025 |
| SDGR | See Remarks | Option Exercise | 1,393 | $4.34 | $6,046 | Oct 15, 2021 |
| SDGR | See Remarks | Option Exercise | 1,394 | $4.34 | $6,050 | Sep 15, 2021 |
| SDGR | See Remarks | Option Exercise | 13,377 | $3.22 | $43,074 | Aug 16, 2021 |
| SDGR | See Remarks | Sale | 800 | $76.08 | $60,864 | Jun 8, 2021 |
| SDGR | See Remarks | Sale | 13,377 | $80.00 | $1,070,160 | Dec 18, 2020 |
| SDGR | See Remarks | Sale | 100 | $70.04 | $7,004 | Aug 17, 2020 |
| SDGR | See Remarks | Sale | 2,697 | $66.53 | $179,431 | Aug 12, 2020 |